Associate Clinical Professor, Washington University in St. Louis; President, Midwest Research Group; Board of Directors, APSARD; Editorial Board, Journal of Attention Disorders
St.Charles Psychiatric Associates
Washington University School of Medicine
Dr. Mattingly is a physician and principal investigator in clinical trials for Midwest Research Group. He is also a founding partner of St. Charles Psychiatric Associates where he treats children, adolescents and adults. A St Louis native, he earned his medical degree and received a Fulbright scholarship while attending Washington University. Dr. Mattingly is board certified in adult and adolescent psychiatry and is a Diplomat of the National Board of Medical Examiners. He is an Associate Clinical Professor at Washington University where he teaches psychopharmacology courses for the 3rd year medical students. Dr. Mattingly has been a principal investigator in over 400 clinical trials focusing on ADHD, anxiety disorders, major depression, bipolar disorder and schizophrenia. Having served on numerous national and international advisory panels, Dr. Mattingly has received awards and distinctions for clinical leadership and neuroscience research. Dr. Mattingly currently serves on the board of directors for APSARD-The American Professional Society of ADHD and Related Disorders and is a certified evaluator for the NFL regarding ADHD and head concussions. He also serves on the board of Headway House, a community support program for individuals with chronic mental illness. An avid runner and outdoorsman, Dr. Mattingly believes mind, body and spirit are important qualities for him and his family.
Welcome Session Featuring Kay Redfield Jamison
Wednesday, September 6, 2023
1:45 PM – 3:15 PM CT
Putting it All Together in Bipolar Disorder: Novel Treatment Options Focused on the Whole Patient
Wednesday, September 6, 2023
5:00 PM – 6:15 PM CT
Emerging Technologies and Digital Tools for the Management of ADHD
Thursday, September 7, 2023
9:00 AM – 10:15 AM CT
Atypical Antipsychotics for Adjunctive Treatment of MDD: Advancing the Standard of Care
Thursday, September 7, 2023
10:30 AM – 11:45 AM CT
Navigating the Stimulant Crisis
Thursday, September 7, 2023
1:30 PM – 2:45 PM CT
Expert Panel: Real-World Impact of Rapid-Acting Antidepressants
Thursday, September 7, 2023
4:30 PM – 5:45 PM CT
Friday, September 8, 2023
10:30 AM – 11:45 AM CT
Solving Clinical Challenges: Focus on ADHD
Friday, September 8, 2023
3:45 PM – 5:00 PM CT
Saturday, September 9, 2023
10:30 AM – 11:45 AM CT
Transforming the Definition of Wellness Focusing on the Whole Person
Saturday, September 9, 2023
5:15 PM – 6:30 PM CT